Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-20 of 29

Sort by

Sort Order Select

Journal Articles

AXL/WRNIP1 Mediates Replication Stress Response and Promotes Therapy Resistance and Metachronous Metastasis in HER2⁺ Breast Cancer

Cancer Res (2024) 84 (5): 675–687.

https://doi.org/10.1158/0008-5472.CAN-23-1459

Published: 04 March 2024

View articletitled, AXL/WRNIP1 Mediates Replication Stress Response and Promotes Therapy Resistance and Metachronous Metastasis in HER2+ Breast Cancer

Includes: Supplementary data

Journal Articles

Abstract PD3-04: Multi-omics characterization of triple-negative breast cancer identifies therapeutic vulnerabilities and epigenetic immune suppression in the mesenchymal subtype

Brian D Lehmann, Antonio Colaprico, Tiago C Silva, Jianjiao Chen, Hanbing An, Yuguang Ban, Lily Wang, Jamaal L James, Justin Balko, Paula I Gonzalez-Ericsson, Melinda E Sanders, Bing Zhang, Jennifer A Pietenpol, Xi S Chen

Cancer Res (2022) 82 (4_Supplement): PD3-04.

https://doi.org/10.1158/1538-7445.SABCS21-PD3-04

Published: 15 February 2022

View articletitled, Abstract PD3-04: Multi-omics characterization of triple-negative breast cancer identifies therapeutic vulnerabilities and epigenetic immune suppression in the mesenchymal subtype

Journal Articles

Abstract P1-04-03: Host myeloid response to tumor and immunotherapy is associated with heterogeneity in outcomes to anti-PDL1

Ann Hanna, Xiaopeng Sun, Paula I. Gonzalez-Ericsson, Violeta M. Sanchez, Melinda E. Sanders, Justin M. Balko

Cancer Res (2022) 82 (4_Supplement): P1-04-03.

https://doi.org/10.1158/1538-7445.SABCS21-P1-04-03

Published: 15 February 2022

View articletitled, Abstract P1-04-03: Host myeloid response to tumor and immunotherapy is associated with heterogeneity in outcomes to anti-PDL1

Journal Articles

Abstract PD9-06: Peripheral blood gene signatures predict response to neoadjuvant chemotherapy in breast cancer patients

Margaret L Axelrod, Paula I Gonzalez-Ericsson, Xiaopeng Sun, Riley E Bergman, Joshua Donaldson, Sara M Tolaney, Ian E Krop, Ana C Garrido-Castro, Melinda E. Sanders, Ingrid A Mayer, Justin M Balko

Cancer Res (2021) 81 (4_Supplement): PD9-06.

https://doi.org/10.1158/1538-7445.SABCS20-PD9-06

Published: 15 February 2021

View articletitled, Abstract PD9-06: Peripheral blood gene signatures predict response to neoadjuvant chemotherapy in breast cancer patients

Journal Articles

Abstract PS17-14: Evaluating the efficacy of immunotherapy in triple negative breast cancer

Ann Hanna, Paula I. Gonzalez-Ericsson, Violeta Sanchez, Melinda E. Sanders, Justin M. Balko

Cancer Res (2021) 81 (4_Supplement): PS17-14.

https://doi.org/10.1158/1538-7445.SABCS20-PS17-14

Published: 15 February 2021

View articletitled, Abstract PS17-14: Evaluating the efficacy of immunotherapy in triple negative breast cancer

Journal Articles

Abstract PD5-07: The immune landscape of residual triple-negative breast cancers after neoadjuvant chemotherapy

Paula I Gonzalez-Ericsson, Violeta Sanchez, Roberto Salgado, Jennifer Bordeaux, Ju Y Kim, Christine Vaupel, Henry Gomez, Melinda E Sanders, Justin M Balko

Cancer Res (2020) 80 (4_Supplement): PD5-07.

https://doi.org/10.1158/1538-7445.SABCS19-PD5-07

Published: 15 February 2020

View articletitled, Abstract PD5-07: The immune landscape of residual triple-negative breast cancers after neoadjuvant chemotherapy

Journal Articles

Abstract P3-08-15: Immunologic correlates of long-term outcome in the residual disease of triple-negative breast cancer after neoadjuvant chemotherapy

Justin M Balko, Mellissa Nixon, Paula I Gonzalez-Ericsson, Mark A Pilkinton, Wyatt J McDonnell, Violeta Sanchez, Susan R Opalenik, Sherene Loi, Brent Rexer, Vandana Abramson, Valerie Jansen, Simon Mallal, Jonathan D Marotti, Kevin Shee, Todd W Miller, Melinda E Sanders, Ingrid A Mayer, Roberto Salgado

Cancer Res (2020) 80 (4_Supplement): P3-08-15.

https://doi.org/10.1158/1538-7445.SABCS19-P3-08-15

Published: 15 February 2020

View articletitled, Abstract P3-08-15: Immunologic correlates of long-term outcome in the residual disease of triple-negative breast cancer after neoadjuvant chemotherapy

Journal Articles

Abstract 1511: MEK activation modulates immunosuppressive MDSCs and metabolic phenotypes in TNBC

Derek A. Franklin, Joe T. Sharick, Paula I. Ericsson-Gonzalez, Violeta Sanchez, Phillip T. Dean, Susan R. Opalenik, Stefano Cairo, Jean-Gabriel Judde, Michael T. Lewis, Jenny C. Chang, Melinda E. Sanders, Rebecca S. Cook, Melissa C. Skala, Jennifer Bordeaux, Jehovana Orozco Bender, Christine Vaupel, Gary Geiss, Douglas Hinerfeld, Justin M. Balko

Cancer Res (2019) 79 (13_Supplement): 1511.

https://doi.org/10.1158/1538-7445.AM2019-1511

Published: 01 July 2019

View articletitled, Abstract 1511: MEK activation modulates immunosuppressive MDSCs and metabolic phenotypes in TNBC

Journal Articles

Correction: Kinome-Wide RNA Interference Screen Reveals a Role for PDK1 in Acquired Resistance to CDK4/6 Inhibition in ER-Positive Breast Cancer

Valerie M. Jansen, Neil E. Bhola, Joshua A. Bauer, Luigi Formisano, Kyung-Min Lee, Katherine E. Hutchinson, Agnieszka K. Witkiewicz, Preston D. Moore, Mónica Valéria Estrada, Violeta Sánchez, Paula G. Ericsson, Melinda E. Sanders, Paula R. Pohlmann, Michael J. Pishvaian, David A. Riddle, Teresa C. Dugger, Wenyi Wei, Erik S. Knudsen, Carlos L. Arteaga

Cancer Res (2019) 79 (4): 874.

https://doi.org/10.1158/0008-5472.CAN-18-4086

Published: 15 February 2019

View articletitled, Correction: Kinome-Wide RNA Interference Screen Reveals a Role for PDK1 in Acquired Resistance to CDK4/6 Inhibition in ER-Positive Breast Cancer

Journal Articles

Correction: Extracellular Matrix/Integrin Signaling Promotes Resistance to Combined Inhibition of HER2 and PI3K in HER2⁺ Breast Cancer

Ariella B. Hanker, Mónica Valeria Estrada, Giampaolo Bianchini, Preston D. Moore, Junfei Zhao, Feixiong Cheng, James P. Koch, Luca Gianni, Darren R. Tyson, Violeta Sánchez, Brent N. Rexer, Melinda E. Sanders, Zhongming Zhao, Thomas P. Stricker, Carlos L. Arteaga

Cancer Res (2019) 79 (4): 873.

https://doi.org/10.1158/0008-5472.CAN-18-4085

Published: 15 February 2019

View articletitled, Correction: Extracellular Matrix/Integrin Signaling Promotes Resistance to Combined Inhibition of HER2 and PI3K in HER2+ Breast Cancer

Journal Articles

Abstract 2982: Somatic TP53 mutations alter the immune microenvironmentafter chemotherapy in breast cancer

Mellissa J. Nixon, V. Monica Estrada, Susan R. Opalenki, Donna Hicks, Michael Korrer, Melinda E. Sanders, Roberto Salgado, Young Kim, Rebecca Cook, Carlos L. Arteaga, Justin M. Balko

Cancer Res (2018) 78 (13_Supplement): 2982.

https://doi.org/10.1158/1538-7445.AM2018-2982

Published: 01 July 2018

View articletitled, Abstract 2982: Somatic TP53 mutations alter the immune microenvironmentafter chemotherapy in breast cancer

Journal Articles

Abstract 2398: Tumor cell-adipocyte gap junctions activate lipolysis in breast cancer

Cancer Res (2018) 78 (13_Supplement): 2398.

https://doi.org/10.1158/1538-7445.AM2018-2398

Published: 01 July 2018

View articletitled, Abstract 2398: Tumor cell-adipocyte gap junctions activate lipolysis in breast cancer

Journal Articles

Abstract 1008: Gain-of-function kinase library screen identifies FGFR1 amplification as a mechanism of resistance to antiestrogens and CDK4/6 inhibitors in ER+ breast cancer

Luigi Formisano, Yao Lu, Valerie M. Jansen, Joshua A. Bauer, Ariella B. Hanker, Melinda E. Sanders, Paula González-Ericsson, Sunkyu Kim, Monica Arnedos, Fabrice André, Carlos L. Arteaga

Cancer Res (2017) 77 (13_Supplement): 1008.

https://doi.org/10.1158/1538-7445.AM2017-1008

Published: 01 July 2017

View articletitled, Abstract 1008: Gain-of-function kinase library screen identifies FGFR1 amplification as a mechanism of resistance to antiestrogens and CDK4/6 inhibitors in ER+ breast cancer

Journal Articles

Extracellular Matrix/Integrin Signaling Promotes Resistance to Combined Inhibition of HER2 and PI3K in HER2⁺ Breast Cancer

Cancer Res (2017) 77 (12): 3280–3292.

https://doi.org/10.1158/0008-5472.CAN-16-2808

Published: 14 June 2017

View articletitled, Extracellular Matrix/Integrin Signaling Promotes Resistance to Combined Inhibition of HER2 and PI3K in HER2+ Breast Cancer

Includes: Supplementary data

Journal Articles

Kinome-Wide RNA Interference Screen Reveals a Role for PDK1 in Acquired Resistance to CDK4/6 Inhibition in ER-Positive Breast Cancer

Cancer Res (2017) 77 (9): 2488–2499.

https://doi.org/10.1158/0008-5472.CAN-16-2653

Published: 30 April 2017

View articletitled, Kinome-Wide RNA Interference Screen Reveals a Role for PDK1 in Acquired Resistance to CDK4/6 Inhibition in ER-Positive Breast Cancer

Includes: Supplementary data

Journal Articles

Abstract 4241: Predicting clinical response in breast cancer using cellular-resolution optical metabolic imaging

Joe T. Sharick, Alex J. Walsh, Melinda E. Sanders, Ingrid Meszoely, Mary A. Hooks, Mark C. Kelley, Melissa C. Skala

Cancer Res (2016) 76 (14_Supplement): 4241.

https://doi.org/10.1158/1538-7445.AM2016-4241

Published: 15 July 2016

View articletitled, Abstract 4241: Predicting clinical response in breast cancer using cellular-resolution optical metabolic imaging

Journal Articles

Abstract 2000: Proteomic features of histological compartments in colorectal carcinoma

Robbert JC Slebos, Lisa J. Zimmerman, Suzanne Manning, Melinda E. Sanders, Chanjuan Shi, M Kay Washington, Daniel C. Liebler

Cancer Res (2015) 75 (15_Supplement): 2000.

https://doi.org/10.1158/1538-7445.AM2015-2000

Published: 01 August 2015

View articletitled, Abstract 2000: Proteomic features of histological compartments in colorectal carcinoma

Journal Articles

Abstract P3-06-32: Genetic heterogeneity for Her2 accounts for a significant percentage of breast cancers changing Her2 status following implementation of the 2013 CAP/ASCO HER2 reporting guidelines

Monica V Estrada, Jena M Giltnane, Ferrin C Wheeler, Ashwini Yenamandra, Vandana Abramson, Ingrid A Mayer, Julie Means, Brent Rexer, Ingrid M Meszoely, Melinda E Sanders

Cancer Res (2015) 75 (9_Supplement): P3-06-32.

https://doi.org/10.1158/1538-7445.SABCS14-P3-06-32

Published: 01 May 2015

View articletitled, Abstract P3-06-32: Genetic heterogeneity for Her2 accounts for a significant percentage of breast cancers changing Her2 status following implementation of the 2013 CAP/ASCO HER2 reporting guidelines

Journal Articles

Abstract P3-04-03: PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors

Brian D Lehmann, Joshua A Bauer, Johanna M Schafer, Christopher S Pendleton, Luojia Tang, Kimberly C Johnson, Xi Chen, Justin M Balko, Henry Gomez, Carlos L Arteaga, Gordon B Mills, Melinda E Sanders, Jennifer A Pietenpol

Cancer Res (2015) 75 (9_Supplement): P3-04-03.

https://doi.org/10.1158/1538-7445.SABCS14-P3-04-03

Published: 01 May 2015

View articletitled, Abstract P3-04-03: PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors

Journal Articles

Abstract P3-06-38: Optical metabolic imaging predicts therapeutic response in breast cancer tumors and organoids

Alex J Walsh, Rebecca S Cook, Melinda E Sanders, Carlos L Arteaga, Melissa C Skala

Cancer Res (2015) 75 (9_Supplement): P3-06-38.

https://doi.org/10.1158/1538-7445.SABCS14-P3-06-38

Published: 01 May 2015

View articletitled, Abstract P3-06-38: Optical metabolic imaging predicts therapeutic response in breast cancer tumors and organoids

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

AXL/WRNIP1 Mediates Replication Stress Response and Promotes Therapy Resistance and Metachronous Metastasis in HER2⁺ Breast Cancer

Abstract PD3-04: Multi-omics characterization of triple-negative breast cancer identifies therapeutic vulnerabilities and epigenetic immune suppression in the mesenchymal subtype

Abstract P1-04-03: Host myeloid response to tumor and immunotherapy is associated with heterogeneity in outcomes to anti-PDL1

Abstract PD9-06: Peripheral blood gene signatures predict response to neoadjuvant chemotherapy in breast cancer patients

Abstract PS17-14: Evaluating the efficacy of immunotherapy in triple negative breast cancer

Abstract PD5-07: The immune landscape of residual triple-negative breast cancers after neoadjuvant chemotherapy

Abstract P3-08-15: Immunologic correlates of long-term outcome in the residual disease of triple-negative breast cancer after neoadjuvant chemotherapy

Abstract 1511: MEK activation modulates immunosuppressive MDSCs and metabolic phenotypes in TNBC

Correction: Kinome-Wide RNA Interference Screen Reveals a Role for PDK1 in Acquired Resistance to CDK4/6 Inhibition in ER-Positive Breast Cancer

Correction: Extracellular Matrix/Integrin Signaling Promotes Resistance to Combined Inhibition of HER2 and PI3K in HER2⁺ Breast Cancer

Abstract 2982: Somatic TP53 mutations alter the immune microenvironmentafter chemotherapy in breast cancer

Abstract 2398: Tumor cell-adipocyte gap junctions activate lipolysis in breast cancer

Abstract 1008: Gain-of-function kinase library screen identifies FGFR1 amplification as a mechanism of resistance to antiestrogens and CDK4/6 inhibitors in ER+ breast cancer

Extracellular Matrix/Integrin Signaling Promotes Resistance to Combined Inhibition of HER2 and PI3K in HER2⁺ Breast Cancer

Kinome-Wide RNA Interference Screen Reveals a Role for PDK1 in Acquired Resistance to CDK4/6 Inhibition in ER-Positive Breast Cancer

Abstract 4241: Predicting clinical response in breast cancer using cellular-resolution optical metabolic imaging

Abstract 2000: Proteomic features of histological compartments in colorectal carcinoma

Abstract P3-06-32: Genetic heterogeneity for Her2 accounts for a significant percentage of breast cancers changing Her2 status following implementation of the 2013 CAP/ASCO HER2 reporting guidelines

Abstract P3-04-03: PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors

Abstract P3-06-38: Optical metabolic imaging predicts therapeutic response in breast cancer tumors and organoids

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only